Cite
Van Ophoven A, Ng CP, Patel B, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: first results and review of the literature. Prostate Cancer Prostatic Dis. 1999;2(5):227-233doi: 10.1038/sj.pcan.4500373.
Van Ophoven, A., Ng, C. P., Patel, B., Bonavida, B., & Belldegrun, A. (1999). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: first results and review of the literature. Prostate cancer and prostatic diseases, 2(5), 227-233. https://doi.org/10.1038/sj.pcan.4500373
Van Ophoven, A, et al. "Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: first results and review of the literature." Prostate cancer and prostatic diseases vol. 2,5 (1999): 227-233. doi: https://doi.org/10.1038/sj.pcan.4500373
Van Ophoven A, Ng CP, Patel B, Bonavida B, Belldegrun A. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: first results and review of the literature. Prostate Cancer Prostatic Dis. 1999 Dec;2(5):227-233. doi: 10.1038/sj.pcan.4500373. PMID: 12497168.
Copy
Download .nbib